Back to LGND Stock Lookup

LGND – FDA

Mar 18, 2014 02:50 PM Roth Still Bullish on Ligand Pharma (LGND) Following NOXAFIL Approval (MRK)
Feb 28, 2014 12:19 PM Roth Still Positive on Ligand (LGND) Following Promacta sNDA Submission
Feb 28, 2014 11:54 AM Ligand Pharma (LGND), Glaxo (GSK) Submit sNDA for Promacta to FDA
Feb 3, 2014 09:55 AM Roth Keeps Ligand (LGND) at Buy; BD Indication for Promacta is Pleasant Surprise
Feb 3, 2014 07:32 AM Ligand Pharma (LGND) Reports Glaxo (GSK) Granted Breakthrough Designation by FDA for Promacta/Revolade
Oct 7, 2013 08:01 AM FDA Accepts Ligand Pharma's (LGND) IND for LGD-6972
Oct 3, 2013 04:15 PM Pfizer (PFE) Affirms FDA Approval of Duavee (LGND)
Oct 3, 2013 03:52 PM Ligand Pharma (LGND) Up as Hot-Flash, Osteoporosis Drug Duavee Get FDA Approval (PFE)
Sep 30, 2013 02:51 PM PDUFA, FDA Panel Review Dates at Risk with Gov't Shutdown (AMRN) (LGND)
Sep 24, 2013 07:04 AM Ligand Pharma (LGND) Reports Grating of Additional Indication for Revolade by EC (GSK)
Jul 26, 2013 08:48 AM Ligand (LGND) Reports Positive CHMP Opinion for Glaxo's REVOLADE (GSK)
May 20, 2013 06:45 AM Ligand Pharmaceuticals (LGND) Agreement with Merck KGaA Unit Terminated
Dec 13, 2012 05:12 PM FDA Accepts Pfizer (PFE) Ligand (LGND) NDA For Bazedoxifene/Conjugated Estrogens
Nov 19, 2012 09:20 AM Ligand Pharma (LGND) to resume trading at 9:45AM after FDA approval
Nov 19, 2012 09:11 AM Ligand (LGND), Glaxo (GSK) Receive FDA Approval for PROMACTA in HCV Patients
Nov 19, 2012 09:03 AM Ligand Pharmaceuticals (LGND), GSK's (GSK) promacta approved - Report
Aug 14, 2012 09:52 AM Griffin Securities Reiterates a 'Buy' on Ligand Pharma (LGND); Investors Jumped The Gun...Attractive Opportunity
Jul 25, 2012 07:35 AM Ligand (LGND) Partner GlaxoSmithKline (GSK) Granted Priority Review for Promacta
Jul 23, 2012 08:41 AM Cantor Fitzgerald Maintains a 'Buy' on Ligand Pharma (LGND); Key Partnered Drug is Approved
Jul 20, 2012 11:58 AM UPDATE: Onyx Pharmaceuticals (ONXX) Kyprolis approved
Jun 20, 2012 03:44 PM Ligand Pharma (LGND) Pops Higher Ahead of FDA Committee Vote for Carfilzomib (ONXX)
Jun 11, 2012 08:07 AM Ligand Pharma (LGND) Reports Encouraging Preclinical Data for LGD-6972 as Type 2 Diabetes Treatment
May 30, 2012 10:17 AM Ligand Pharmaceuticals (LGND) Says Glaxo (GSK) Submits Regulatory Apps for Promacta/Revolade
Feb 21, 2012 08:51 AM Ligand (LGND) Licenses DARA to Retrophin; May Get Up to $75M in Milestone Payments
Feb 2, 2012 06:47 AM Ligand Pharma (LGND) Completes PG-Free Melphalan Phase II, Issues Update
Dec 27, 2011 08:37 AM Ligand (LGND) Unit Enters $3M Captisol Supply Agreement with Hospira (HSP)
Nov 2, 2011 08:15 AM Ligand Pharma (LGND) Reports Melphalan Met All Endpoints in Phase II Study
Jul 26, 2011 07:16 AM Ligand Pharmaceuticals (LGND) Partner GlaxoSmithKline (GSK) Receives Positive Data from Promacta PIII ENABLE1 Study
Jun 3, 2011 10:27 AM Ligand Pharma (LGND) Licenses Captisol-Enabled Clopidogrel from The Medicines Co. (MDCO)
Nov 2, 2010 09:24 AM Ligand Pharma (LGND) Announces Glaxo (GSK) Receives O.K. in Japan for Revolade
Oct 13, 2010 08:13 AM Ligand Pharma (LGND) Announces Launch of Viviant in Japan (PFE)
Apr 20, 2010 08:38 AM Ligand Pharma (LGND) To Receive $6.5M Milestone Payment from Roche (RHHBY)
Mar 12, 2010 12:22 PM Ligand Pharma (LGND) Announces that Glaxo (GSK) was Approved for Revolade Marketing in Europe
Dec 18, 2009 09:10 AM Ligand Pharma (LGND) Partner Glaxo (GSK) Receives Positive Opinion for Revolade from CHMP
Mar 24, 2009 04:20 PM Ligand Pharmaceuticals (LGND) and Pfizer (PFE) Receive EC Approval for FABLYN
Nov 21, 2008 07:24 AM Ligand Pharma (LGND) Partner GlaxoSmithKline's Granted Accelerated Approval of PROMACTA
Jun 20, 2008 04:03 PM Ligand Pharmaceuticals (LGND) Partner GlaxoSmithKline (GSK) Receives FDA Extended Priority Review for PROMACTA(R) NDA
Apr 24, 2008 09:41 AM Ligand (LGND) Initiates Phase II Trial with LGD-4665 in Idiopathic Thrombocytopenic Purpura
Dec 20, 2007 08:04 AM Ligand Pharmaceuticals (LGND) Receives $1M Milestone Payment From GSK
Sep 7, 2006 08:09 AM King Pharmaceuticals (KG) Buys AVINZA Rights from Ligand Pharmaceuticals (LGND)
Jun 26, 2006 09:17 AM Ligand Pharmaceuticals (LGND) Earns Milestone Payment From Wyeth (WYE)
Feb 14, 2006 08:36 AM LGND Earns $2M Milestone Payment from GlaxoSmithKline
Dec 14, 2005 11:56 PM LGND Presents Positive Trial Data on Cancer Drug ONTAK
Dec 2, 2005 10:30 AM LGND Said Collaborator Drug Shows Encouraging Results
Aug 18, 2005 08:56 AM LGNDE Second Manufacturing Source for AVINZA Approved by FDA
Jul 19, 2005 11:16 PM FDA Asks LGNDE to Make Label Changes to AVINZA
Jul 13, 2005 11:20 PM LGNDE Earns $1.6M Milestone Payment form LLY
Apr 4, 2005 11:14 PM LGNDE Earned $1.5M Milestone Payment from TAP Pharmaceutical
Feb 7, 2005 11:36 PM LGND Receives $1M Milestone Payment from GSK
Feb 3, 2005 09:03 AM LGND Says Pfizer Submits SNDA for Lasofoxifene

Back to LGND Stock Lookup